The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trial.
- ID
008c128df38f4855- Source org
- Europe PMC
- Author
- Francisco García‐Torres (Instituto Maimónides de Investigación Biomédica de Córdoba), Margarita García-Carmona (Instituto Maimónides de Investigación Biomédica de Córdoba), Ángel Gómez-Solís (Hospital Universitario Reina Sofía), Sebastián Rubio García (Instituto Maimónides de Investigación Biomédica de Córdoba), Rosario Castillo-Mayén (Instituto Maimónides de Investigación Biomédica de Córdoba), Bárbara Luque (Instituto Maimónides de Investigación Biomédica de Córdoba), Francisco Jurado-González (Instituto Maimónides de Investigación Biomédica de Córdoba), Marcin Jablonski (Akademia Ignatianum w Krakowie), Enrique Aranda (Hospital Universitario Reina Sofía)
- Published
- 2026-01-01
- OA status
- gold
- DOI
- 10.1016/j.ijchp.2026.100668
- PMID
- Not recorded
- PMCID
- PMC12972512
- Citations
- 0
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-21T15:41:41.820142+00:00
Cite this entry
BibTeX
@article{allodium:008c128df38f4855,
title = {The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trial.},
author = {Francisco García‐Torres and Margarita García-Carmona and Ángel Gómez-Solís and Sebastián Rubio García and Rosario Castillo-Mayén and Bárbara Luque and Francisco Jurado-González and Marcin Jablonski and Enrique Aranda},
year = {2026},
journal = {Europe PMC},
doi = {10.1016/j.ijchp.2026.100668},
url = {https://doi.org/10.1016/j.ijchp.2026.100668}
}RIS
TY - JOUR TI - The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trial. AU - García‐Torres, Francisco AU - García-Carmona, Margarita AU - Gómez-Solís, Ángel AU - García, Sebastián Rubio AU - Castillo-Mayén, Rosario AU - Luque, Bárbara AU - Jurado-González, Francisco AU - Jablonski, Marcin AU - Aranda, Enrique PY - 2026 PB - Europe PMC DO - 10.1016/j.ijchp.2026.100668 UR - https://doi.org/10.1016/j.ijchp.2026.100668 ER -
APA
García‐Torres, F., García-Carmona, M., Gómez-Solís, Á., García, S. R., Castillo-Mayén, R., Luque, B., Jurado-González, F., Jablonski, M., & Aranda, E. (2026). The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trial.. Europe PMC. https://doi.org/10.1016/j.ijchp.2026.100668
Related entries
- The effects of acceptance and commitment therapy (ACT) on psychological and physical outcomes among cancer patients and survivors: An umbrella review
- Acceptance and commitment therapy among caregivers of people with cancer: a systematic review and meta-analysis.
- Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life
- Acceptance and commitment therapy reduces psychological distress in patients with cancer: a systematic review and meta-analysis of randomized controlled trials
- Enhancing Well-Being in Cancer Survivors Through Acceptance and Commitment Therapy: A Randomized Clinical Trial.
- The effectiveness of internet-based acceptance and commitment therapy on acceptance of illness, emotion regulation, symptom severity reduction, and symptoms interference with function in patients with breast cancer
- Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings
- A web-based self-help intervention for partners of cancer patients based on Acceptance and Commitment Therapy: a protocol of a randomized controlled trial
- Psychological support for patients with cancer: evidence review and suggestions for future directions
- Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trial